日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS

特立氟胺治疗复发型多发性硬化症患儿:TERIKIDS 研究的开放标签扩展研究

Chitnis, Tanuja; Banwell, Brenda; Kappos, Ludwig; Arnold, Douglas L; Gücüyener, Kivilcim; Deiva, Kumaran; Saubadu, Stephane; Hu, Wenruo; Benamor, Myriam; Le-Halpere, Annaig; Truffinet, Philippe; Tardieu, Marc

Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis

Gatralimab(一种新一代人源化抗CD52单克隆抗体)在进行性多发性硬化症患者中的I期试验

Albach, Fredrik N; Geier, Christian; Keicher, Christian; Posch, Maximilian G; Schreiber, Stephan J; Grütz, Gerald; Akyüz, Levent; Luo, Xiaodong; Le-Halpere, Annaig; Truffinet, Philippe; Wagner, Frank

Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial

接受特立氟胺或安慰剂治疗的复发型多发性硬化症患儿血浆神经丝轻链水平:一项随机 TERIKIDS 试验的事后分析

Kuhle, Jens; Chitnis, Tanuja; Banwell, Brenda; Tardieu, Marc; Arnold, Douglas L; Rawlings, Andreea M; Geertsen, Svend S; Lublin, Alex L; Saubadu, Stephane; Truffinet, Philippe; Kappos, Ludwig

Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide

接受特立氟胺治疗的多发性硬化症患者的疫苗反应

Tornatore, Carlo; Wiendl, Heinz; Lublin, Alex L; Geertsen, Svend S; Chavin, Jeffrey; Truffinet, Philippe; Bar-Or, Amit

Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials

长期特立氟胺治疗对淋巴细胞计数和感染率的影响:临床试验汇总分析

Comi, Giancarlo; Miller, Aaron E; Benamor, Myriam; Truffinet, Philippe; Poole, Elizabeth M; Freedman, Mark S

Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO

预测接受特立氟胺治疗的多发性硬化症患者的长期残疾结局(TEMSO)。

Sormani, Maria Pia; Truffinet, Philippe; Thangavelu, Karthinathan; Rufi, Pascal; Simonson, Catherine; De Stefano, Nicola

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study

特立氟胺的长期安全性和有效性:TEMSO随机研究的九年随访

O'Connor, Paul; Comi, Giancarlo; Freedman, Mark S; Miller, Aaron E; Kappos, Ludwig; Bouchard, Jean-Pierre; Lebrun-Frenay, Christine; Mares, Jan; Benamor, Myriam; Thangavelu, Karthinathan; Liang, Jinjun; Truffinet, Philippe; Lawson, Victoria J; Wolinsky, Jerry S

Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens

特立氟胺对新抗原和记忆抗原免疫反应影响的随机研究

Bar-Or, Amit; Wiendl, Heinz; Miller, Barry; Benamor, Myriam; Truffinet, Philippe; Church, Meg; Menguy-Vacheron, Francoise

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis

特立氟胺对多发性硬化症患者流感疫苗免疫反应的影响

Bar-Or, Amit; Freedman, Mark S; Kremenchutzky, Marcelo; Menguy-Vacheron, Françoise; Bauer, Deborah; Jodl, Stefan; Truffinet, Philippe; Benamor, Myriam; Chambers, Scott; O'Connor, Paul W

Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years

一项口服特立氟胺治疗复发型多发性硬化症的 II 期研究的长期随访:长达 8.5 年的安全性和有效性结果

Confavreux, Christian; Li, David K; Freedman, Mark S; Truffinet, Philippe; Benzerdjeb, Hadj; Wang, Dazhe; Bar-Or, Amit; Traboulsee, Anthony L; Reiman, Lucy E; O'Connor, Paul W